Huober J, Weder P, Veyret C. et al.
PERNETTA – A non comparative randomized open label phase II trial of pertuzumab (P) + trastuzumab (T) with or without chemotherapy both followed by T-DM1 in case of progression, in
patients with HER2 positive metastatic breast cancer (SAKK 22/10/UNICANCER UC-0140/1207).
Ann Oncol 2018;
Download Bibliographical Data